Nutritional Problems After Lung and Heart Transplantation
Primary Purpose
Bone Density, Overweight
Status
Unknown status
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Vitamin K
Vitamin K
Sponsored by
About this trial
This is an interventional prevention trial for Bone Density focused on measuring vitamin K, Bone Mineral Density, undercarboxylated osteocalcin
Eligibility Criteria
Inclusion Criteria:
- accepted for transplantation
Exclusion Criteria:
- not accepted for transplantation
Sites / Locations
- Rikshospitalet HF
Outcomes
Primary Outcome Measures
plasma vitamin K
Secondary Outcome Measures
Bone mineral density
Full Information
NCT ID
NCT00826254
First Posted
January 21, 2009
Last Updated
July 3, 2011
Sponsor
Oslo University Hospital
Collaborators
Norwegian Foundation for Health and Rehabilitation
1. Study Identification
Unique Protocol Identification Number
NCT00826254
Brief Title
Nutritional Problems After Lung and Heart Transplantation
Official Title
Nutritional Problems After Lung and Heart Transplantation
Study Type
Interventional
2. Study Status
Record Verification Date
January 2009
Overall Recruitment Status
Unknown status
Study Start Date
August 2003 (undefined)
Primary Completion Date
April 2007 (Actual)
Study Completion Date
December 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Oslo University Hospital
Collaborators
Norwegian Foundation for Health and Rehabilitation
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Part 1) Bone health after transplantation - possible influence of vitamin K
Part 2) Fat metabolism and endocrine parameters - possible predictors for developement of overweight after transplantation
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bone Density, Overweight
Keywords
vitamin K, Bone Mineral Density, undercarboxylated osteocalcin
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
94 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Vitamin K
Other Intervention Name(s)
Natto
Intervention Description
180 micrograms vitamin K daily
Intervention Type
Drug
Intervention Name(s)
Vitamin K
Other Intervention Name(s)
Natto
Intervention Description
2 capsules daily 180 micrograms vitamin K daily or placebo
1 year
Primary Outcome Measure Information:
Title
plasma vitamin K
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Bone mineral density
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
accepted for transplantation
Exclusion Criteria:
not accepted for transplantation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Liv Forli, Dr
Organizational Affiliation
Oslo University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Liv Forli, Dr
Organizational Affiliation
Oslo University Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Oystein Bjortuft, MD
Organizational Affiliation
Oslo University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Rikshospitalet HF
City
Oslo
Country
Norway
12. IPD Sharing Statement
Learn more about this trial
Nutritional Problems After Lung and Heart Transplantation
We'll reach out to this number within 24 hrs